Tyers Asset Management’s United Therapeutics UTHR Stock Holding History

Tyers Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$839K	Sell	10,516 -8,140	-44%	-$656K	0.03%	360
2019 Q2	$1.46M	Sell	18,656 -9,240	-33%	-$864K	0.05%	267
2019 Q1	$3.27M	Sell	27,896 -18,150	-39%	-$2.11M	0.11%	162
2018 Q4	$5.01M	Buy	46,046 +3,234	+8%	+$375K	0.2%	108
2018 Q3	$5.47M	Buy	42,812 +11,220	+36%	+$1.39M	0.18%	125
2018 Q2	$3.58M	Buy	31,592 +6,512	+26%	+$716K	0.12%	157
2018 Q1	$2.82M	Buy	25,080 +18,524	+283%	+$2.35M	0.1%	175
2017 Q4	$970K	Buy	6,556 +2,530	+63%	+$322K	0.03%	288
2017 Q3	$472K	Sell	4,026 -12,870	-76%	-$1.64M	0.02%	419
2017 Q2	$2.19M	Sell	16,896 -6,182	-27%	-$771K	0.08%	195
2017 Q1	$3.12M	Sell	23,078 -9,856	-30%	-$1.49M	0.12%	157
2016 Q4	$4.72M	Buy	+32,934	New	+$4.2M	0.2%	92

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Tyers Asset Management's UTHR Position: Q3 2019 in Review

Tyers Asset Management reduced its United Therapeutics (UTHR) stake by 44% in Q3 2019, selling an estimated $656K and leaving 10,516 shares worth $839K. The position accounts for 0.03% of the portfolio, ranked #360.

Tyers Asset Management first reported a position in UTHR in Q4 2016 and has held it in 12 quarters since. The position peaked at $5.47M in Q3 2018. 302 funds tracked by Wall St. Rank hold UTHR as of Q3 2019.

Tyers Asset Management held 10,516 shares of United Therapeutics worth $839K as of Q3 2019.
Tyers Asset Management sold 8,140 United Therapeutics shares in Q3 2019, an estimated $656K.
United Therapeutics made up 0.03% of Tyers Asset Management's portfolio in Q3 2019, its #360 holding.
Tyers Asset Management first reported a position in United Therapeutics in Q4 2016 and has held it in 12 quarters since.
Tyers Asset Management's United Therapeutics position peaked at $5.47M in Q3 2018.
302 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.